At Manningham Medical Centre, you can find all the data about Tvax Biomedical Ipo. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Biotech firm TVAX Biomedical files for a $40 million IPO

    https://www.renaissancecapital.com/IPO-Center/News/10528/Biotech-firm-TVAX-Biomedical-files-for-a-$40-million-IPO
    TVAX Biomedical, a biotech company focused on cancer cell vacination and T-cell cancer treatment, filed on Monday with the SEC to raise up to $40 million in an initial public …

TVAX Biomedical announces major …

    https://www.prnewswire.com/news-releases/tvax-biomedical-announces-major-advancements-in-potential-glioblastoma-cure-301189098.html
    TVAX Biomedical is a clinical stage development company advancing its proprietary …

TVAX Biomedical Announces Receipt of $2 Million FDA Orphan …

    https://finance.yahoo.com/news/tvax-biomedical-announces-receipt-2-140700766.html
    OLATHE, Kan., Oct. 18, 2022 (GLOBE NEWSWIRE) -- TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma …

TVAX Biomedical Announces Receipt of $2 Million FDA Orphan …

    https://www.marketwatch.com/press-release/tvax-biomedical-announces-receipt-of-2-million-fda-orphan-products-grant-for-glioblastoma-study-2022-10-18
    In September 2022, TVAX Biomedical received an approximately $2 million 4-year grant from the FDA Office of Orphan Products for its planned glioblastoma study. …

TVAX Biomedical - Crunchbase Company …

    https://www.crunchbase.com/organization/tvax-biomedical
    Last Funding Type Grant. Company Type For Profit. Contact Email [email protected]. Phone Number (913) …

TVAX Biomedical, Inc. | LinkedIn

    https://www.linkedin.com/company/tvax-biomedical-inc-
    TVAX Biomedical is a biotechnology company currently performing phase 2b/3 clinical trials to test a unique cancer immunotherapy as a treatment for pediatric brain cancer. Website...

TVAX Biomedical Inc - Company Profile and News

    https://www.bloomberg.com/profile/company/TVAX:US
    TVAX Biomedical Inc. is a biotechnology company focused on the development of targeted cell-based immunotherapies for the treatment of cancer. The Company's …

TVAX Biomedical withdraws $20 million IPO - Renaissance Capital

    https://www.renaissancecapital.com/IPO-Center/News/11789/TVAX-Biomedical-withdraws-$20-million-IPO
    TVAX Biomedical, a biotech company focused on cancer cell vacination and T cell cancer treatment, withdrew its plans for an initial public offering on Thursday, citing …

TVAX Biomedical Raises $2.0 Million in Private Financing; …

    https://finance.yahoo.com/news/tvax-biomedical-raises-2-0-124500053.html
    LENEXA, KS-- (Marketwire - Jan 7, 2013) - TVAX Biomedical, a clinical stage development company advancing its proprietary cell-based immunotherapy for the …

TVAX Biomedical withdraws $20 million IPO | Nasdaq

    https://www.nasdaq.com/articles/tvax-biomedical-withdraws-20-million-ipo-2012-05-18
    TVAX Biomedical, a biotech company focused on cancer cell vacination and T cell cancer treatment, withdrew its plans for an initial public offering. TVAX …



Need more information about Tvax Biomedical Ipo?

At Manningham Medical Centre, we collected data on more than just Tvax Biomedical Ipo. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.